ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare disease free survival of elderly breast cancer
patients treated with standard adjuvant chemotherapy (CMF) versus experimental adjuvant
chemotherapy (weekly docetaxel).